Brainomix 360 Triage ICH

by Brainomix Limited  · Based in United Kingdom → — AI-powered real-time alerts for suspected intracranial hemorrhage
Emergency Medicine Neurology Radiology

Contact vendor
Regulatory Status Disclosed

Overview

Brainomix 360 Triage ICH is an FDA-cleared, AI-powered notification tool designed to provide real-time alerts of suspected intracranial hemorrhage (ICH) to clinicians. The software assesses non-contrast CT (NCCT) scans of the brain from adult patients in acute settings, typically within 24 hours of symptom onset, and generates a priority notification when ICH is detected. This tool is intended to assist hospital networks and trained clinicians in workflow triage by flagging and communicating suspected positive findings to specialists in parallel to standard image interpretation. It supports treatment and transfer decisions for stroke patients, helping to optimize workflow across stroke networks and facilitate faster care. The software also offers basic image viewing through multiple formats and delivers notifications directly to clinicians’ smartphones via a mobile application.

Brainomix 360 Triage ICH is a standalone software device that utilizes machine learning algorithms and advanced imaging analytics. It is compliant with the DICOM standard and can run on off-the-shelf physical or virtual servers. While it provides critical information for triage, it is not intended for diagnostic use beyond notification, and clinicians are responsible for viewing non-compressed images on a diagnostic viewer for final decisions.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Real-time alerts for suspected intracranial hemorrhage (ICH)
  • AI-powered analysis of non-contrast CT (NCCT) scans
  • Smartphone notifications for clinicians
  • Basic image viewing through multiple formats
  • Optimizes workflow across stroke networks
  • Facilitates faster treatment and transfer decisions
  • DICOM compliant software
  • Runs on physical or virtual servers
  • Assists in triage of acute stroke patients
  • Provides priority notifications

Use Cases

  • Triage of patients with suspected intracranial hemorrhage (ICH)
  • Aiding in rapid treatment and transfer decisions for stroke patients
  • Excluding certain treatments (e.g., thrombolysis, thrombectomy) based on ICH presence
  • Optimizing workflow in stroke networks
  • Supporting both specialist and non-specialist centers in stroke care
  • Improving patient outcomes by reducing treatment delays

What Physicians Need to Know

Stroke Detection Speed (ICH)
Brainomix 360 Triage ICH provides real-time alerts for suspected intracranial hemorrhage (ICH), with detection and analysis typically completed in 88 seconds.
Brain CT Analysis (ICH)
The tool specifically assesses non-contrast CT scans to identify and evaluate hyperdense volumes characteristic of acute intracranial hemorrhage.
Triage Prioritization Speed
Designed to optimize workflow across stroke networks, it facilitates faster treatment and transfer decisions by providing real-time notifications of suspected ICH.
Mobile Notification System
Delivers real-time alerts of suspected intracranial hemorrhage directly to clinicians' smartphones, including compressed preview images for informational purposes. Clinicians can also access notifications and images via a web user interface.
Physician Tip

Brainomix 360 Triage ICH is an FDA-cleared notification tool that significantly aids in the rapid identification and triage of intracranial hemorrhage. It should be used as a decision support tool in conjunction with a physician's professional judgment and standard of care image interpretation, not as a primary diagnostic device. The real-time alerts and mobile access can help expedite critical treatment and transfer decisions for stroke patients.

The Brainomix 360 platform, including Triage ICH, is DICOM compliant and operates on an off-the-shelf physical or virtual server. It integrates with existing hospital networks to provide notifications via a web user interface and dedicated mobile applications (Android and iOS), and can send pseudonymized result images via email.

Details

Category Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Contact vendor
DeploymentOn-premise or cloud-based server
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated

Brainomix 360 Triage ICH received FDA clearance (K231195) on July 27, 2023. It is cleared as a notification-only, parallel workflow tool to identify and communicate images suggestive of intracranial hemorrhage on non-contrast CT brain images to specialists.

Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

What the Web Says

Brainomix 360 Triage ICH is an FDA-cleared AI-powered notification tool designed to provide real-time alerts of suspected intracranial hemorrhage (ICH) to clinicians, directly to their smartphones. It assesses non-contrast CT scans and flags the presence of ICH, aiding in rapid treatment and transfer decisions for stroke patients. The software is part of the broader Brainomix 360 Stroke platform, which has demonstrated significant improvements in stroke care workflows and patient outcomes.

Overall: Positive

Strengths

  • High sensitivity (93%) and specificity (94%) for ICH detection.
  • Provides real-time alerts to clinicians' smartphones, facilitating faster treatment decisions.
  • Aids in optimizing workflow across stroke networks.
  • Can help differentiate strokes from 'stroke mimics'.
  • Associated with increased rates of mechanical thrombectomy and reduced delays in patient triage and transfer.
  • Validated in real-world studies with a large patient cohort.

Limitations

  • Mobile app images are for informational purposes only and not for diagnostic use.
  • Not intended to detect isolated subarachnoid hemorrhage or symmetrical bilateral MCA occlusions.
  • Not intended for analyzing CT images in intracranial vascular pathologies such as arterial aneurysms, arteriovenous malformations, or venous thrombosis.
  • False positives for hemorrhage detection can be caused by areas of calcification.
  • Compared to other AI tools, Brainomix literature is less focused on perfusion analysis (Rapid CTP) and LVO detection.
  • Pricing information is not readily available and requires direct contact with sales.

Based on reviews from: NeuroNews, Brainomix, accessdata.fda.gov, Xtalks, Google Play, MDPI, PR Newswire, Diagnostic and Interventional Cardiology, AuntMinnieEurope, G2, Medical Device and Diagnostic industry, Reddit

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Brainomix 360 Triage ICH

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PR Newswire
Brainomix Targets US Expansion with the Launch of its Cutting-Edge Stroke AI Platform Following Series of FDA Clearances
Brainomix announced its continued US expansion and the launch of its full suite of FDA-cleared modules in its Brainomix 360 platform for stroke care, including Brainomix 360 Triage ICH, which provides real-time alerts for suspected intracranial hemorrhage.
2023-11
Medical Device Network
Brainomix expands into US territory with AI platform
Brainomix has announced its expansion into the US market with the launch of its AI platform, Brainomix 360, which includes the Brainomix 360 Triage ICH tool for real-time alerts of suspected intracranial hemorrhage.
2023-11
NeuroNews International
Brainomix targets US expansion following launch of 360 platform at SVIN 2023
Brainomix launched its full suite of FDA-cleared modules in its Brainomix 360 platform for stroke care in the US, featuring Brainomix 360 Triage ICH for real-time alerts of suspected intracranial hemorrhage.
2023-11
AuntMinnie
Brainomix launches AI platform for stroke care
Brainomix has launched its AI platform for stroke care, Brainomix 360, which includes the Triage ICH module to provide real-time notifications for suspected intracranial hemorrhage.
2023-11
PMC (PubMed Central)
Revolutionizing Acute Stroke Care: A Review of Food and Drug Administration-Approved Software as Medical Devices for Stroke Triage
This peer-reviewed article reviews FDA-approved Software as Medical Devices (SaMDs) for stroke triage, listing Brainomix 360 Triage ICH as an AI-enabled device from the UK for detecting intracranial hemorrhage on NCCT head scans with high sensitivity and specificity.
2024-11
FDA.report
Brainomix 360 Triage ICH FDA 510(k) Clearance
The FDA 510(k) clearance document details Brainomix 360 Triage ICH as a notification-only, parallel workflow tool using AI to identify suspected intracranial hemorrhage on non-contrast CT images for adult patients in acute settings.
2023-07
Orthogonal
SaMD Cleared by the FDA: The Ultimate Running List
This comprehensive list of FDA-cleared Software as a Medical Devices (SaMD) includes Brainomix 360 Triage ICH, with its clearance date noted as July 27, 2023, for radiology applications.
2024-10
ResearchGate
The evolving landscape: Role of artificial intelligence in cancer detection
This article discusses the role of AI in cancer detection and lists Brainomix 360 Triage ICH as a notification tool that provides real-time alerts to clinicians, highlighting its broader application beyond just stroke.
2024-05

Videos

Product demos, reviews, and walkthroughs for Brainomix 360 Triage ICH.

View all on YouTube

Frequently Asked Questions

Brainomix 360 Triage ICH is an AI-powered notification tool that analyzes non-contrast CT scans for suspected intracranial hemorrhage and delivers real-time alerts to clinicians, often via smartphones. It is designed to optimize workflow across stroke networks, facilitating faster treatment and transfer decisions, and is DICOM compliant for integration within hospital networks.
Brainomix 360 Triage ICH is an FDA-cleared notification tool specifically for suspected intracranial hemorrhage. Brainomix also holds CE Mark certifications for other modules within its broader e-Stroke platform, demonstrating compliance with European regulatory standards for medical devices.
Brainomix 360 Triage ICH is a notification-only tool and not intended for mobile diagnostic use; mobile images are compressed previews and not for diagnostic interpretation. It should not replace a full patient evaluation or be solely relied upon for diagnosis, and false positives can occur, sometimes due to calcifications.
Brainomix 360 Triage ICH has demonstrated high sensitivity (92.5-93%) and specificity (87.22-94%) for ICH detection in validation studies. While other AI platforms like RapidAI and Viz.ai also exist for stroke assessment, Brainomix shows strong efficacy for ICH and can aid in workflow prioritization.
Specific pricing models for Brainomix 360 Triage ICH are not publicly disclosed, as is typical for specialized medical software. Generally, costs involve licensing fees, implementation for integration with existing hospital systems, and ongoing maintenance and support contracts. Hospitals should contact Brainomix directly for a detailed quote tailored to their specific needs.
Brainomix 360 Triage ICH has been validated in retrospective studies, showing high accuracy for ICH detection. The broader Brainomix 360 Stroke platform, which includes Triage ICH, is supported by over 60 peer-reviewed studies and has been associated with increased mechanical thrombectomy rates and reduced door-in-door-out times in large prospective observational studies.
Brainomix acts as a data processor, handling patient data on behalf of the hospital (the data controller) in compliance with GDPR. Patient data is pseudonymized for email notifications, and the software operates within the hospital's network, protected by firewalls. Imaging data is temporarily stored on Brainomix servers and then securely deleted according to hospital retention policies.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

More from Brainomix

Brainomix 360 e-ASPECTS
Brainomix Limited
Neurology AI
Brainomix 360 e-ASPECTS is an FDA-cleared and CE-marked AI decision support tool that automates and standardizes the ASPECTS score and measures ischemic signs on plain CT brain scans for acute stroke assessment.
Brainomix 360 e-CTA
Brainomix Limited
Clinical Decision Support & Reference
Brainomix 360 e-CTA is an AI-powered module within the Brainomix 360 Stroke platform that automates and standardizes the assessment of collaterals and detects large vessel occlusions on CT angiography scans for acute stroke patients.
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
Brainomix 360 Triage LVO
Brainomix Limited
Neurology AI
Brainomix 360 Triage LVO is an FDA-cleared AI-powered notification tool providing real-time alerts of suspected large vessel occlusion (LVO) to clinicians on their smartphones, evaluating CT angiography scans for critical stroke indicators.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-17 | First Added: 2026-04-17

Investors who backed Brainomix 360 Triage ICH

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.